The Hill - The vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) on Friday voted in favor of changing long-held guidance for newborn hepatitis B vaccinations.
The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 8-3 in favor of altering the recommendation that all newborns receive hepatitis B vaccinations at birth.
The language of the vote was: “For infants born to HBsAg-negative women: ACIP recommends individual-based decision-making, in consultation with a health care provider, for parents deciding when or if to give the HBV vaccine, including the birth dose. A Parents and health care providers should consider vaccine benefits, vaccine risks, and infection risks. For those not receiving the HBV birth dose, it is suggested that the initial dose is administered no earlier than 2 months of age.”
There was a clear divide in the committee, with a minority of panelists strongly opposed to what they believed was a perceived harm that would stem from the vote and the lack of data supporting a change to the guidance.
No comments:
Post a Comment